U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07945704) titled 'GLP-1 RAs and Dietary Intake and Body Composition' on Nov. 06.

Brief Summary: To assess longitudinal changes in dietary intake, body composition and metabolism with GLP-1 RA use.

Study Start Date: June 01

Study Type: OBSERVATIONAL

Condition: Glucagon-Like Peptide-1 Receptor Agonists Metabolism Body Composition

Intervention: DRUG: GLP-1 RAs

Participants currently taking GLP-1 RAs as part of their care

Recruitment Status: RECRUITING

Sponsor: Ohio University

Information provided by (Responsible Party): Angela Hillman, Ohio University

Disclaimer: Curated by HT Syndication....